To avoid anti-kickback litigation with government, pharma companies need a defensible position on FMV assessments
Stephen Rothenberg, Numerof & Associates, Inc.
Advertisement
Articles by Stephen Rothenberg, Numerof & Associates, Inc.
Advertisement
Latest Updated Articles
- Defending Fair Market Value (FMV) Assessments
Published: June 28th 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
US and UK Agree to Zero Tariffs on Pharmaceuticals
2
How DSCSA Compliance Is Unlocking Recall Efficiency
3
New HTI-4 Final Rule Sets Path for Modernized Prescribing and Patient Access
4
Pharma Pulse: US-UK Trade Deal Forces Pricing Shift, as Lilly Deepens GLP-1 Price Cuts and RSV-Asthma Link Confirmed
5
